Choroidal neovascularization

American Journal of Ophthalmology

Volumn 137, Issue 3, 2004, Pages 496-503

  Grossniklaus, Hans E ^a   Green, W Richard ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANECORTAVE; ANGIOPOIETIN; ANTIINFLAMMATORY AGENT; BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN; PEGAPTANIB; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMINOGEN; RANIBIZUMAB; THROMBOPLASTIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE COURSE; DRUG PROTEIN BINDING; HUMAN; LASER COAGULATION; PATHOGENESIS; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REVIEW; SUBRETINAL NEOVASCULARIZATION;

EID: 1542297340     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2003.09.042     Document Type: Article

References (94)

1. Green W.R., Wilson D.J. Choroidal neovascularization. Ophthalmol. 93:1986;1169-1176.
2. Green W.R. The uveal tract. Spencer W.R. Ophthalmic pathology: an atlas and textbook. 1996;1597-1607 WB Saunders, Philadelphia. 4th ed.
3. Green W.R., McDonnell P.J., Yeo J.H. Pathologic features of senile macular degeneration. Ophthalmology. 92:1985;615-627.
4. Green W.R. Clinicopathologic studies of treated choroidal neovascular membranes A review and report of two cases. Retina. 11:1991;328-356.
5. Green W.R., Enger C. Age-related macular degeneration histopathologic studies. Ophthalmology. 100:1993;1519-1535.
6. Grossniklaus H.E., Martinez J.A., Brown V.B., et al. Immunohistochemical and histochemical properties of surgically-excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 154:1992;464-472.
7. Grossniklaus H.E., Hutchinson A.K., Capone A. Jr, et al. Clinicopathologic features of surgically-excised choroidal neovascular membranes. Ophthalmology. 101:1994;1099-1111.
8. Grossniklaus H.E., Green W.R., Submacular Surgery Trials Research Group. Histopathologic and ultrastructural findings of surgically-excised choroidal neovascularization. Arch Ophthalmol. 116:1998;745-749.
9. Grossniklaus H.E., Cingle K.A., Yoon Y.D., et al. Correlation of histologic two-dimensional reconstruction and confocal scanning laser microscopic images in eyes with age-related maculopathy. Arch Ophthalmol. 118:2000;625-629.
10. Grossniklaus H.E., Ling J.X., Wallace T.M., et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis. 8:2002;119-126.
11. Gass J.D.M. Biomicroscopic and histopathologic consideration regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol. 118:1994;285-298.
12. Gass J.D.M. Stereoscopic atlas of macular diseases diagrams and treatment. Vol 1. 1997;26-37 Mosby, St. Louis.
13. Grossniklaus H.E., Gass J.D.M. Clinicopathologic correlation of surgically-excised type 1 and type 2 choroidal neovascular membranes. Am J Ophthalmol. 126:1998;59-69.
14. Lee B.C., Lim J.I., Grossniklaus H.E. Clinicopathologic features of indocyanine green angiographically-imaged, surgically excised choroidal neovascular membranes. Retina. 16:1996;64-69.
15. LaFaut B.A., Bartz-Schmidt K.U., van den Broeecke C., et al. Clinicopathologic correlation in exudative age-related macular degeneration Histological differentiation between classic and occult choroidal neovascularization. Br J Ophthalmol. 84:2000;239-243.
16. Ambati J., Ambati B.K., Yoo S.H., et al. Age-related macular degeneration Etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 48:2003;257-293.
17. Sattler H. Ueber den feineren Bau der Choroidea des Menschen nebst Beiträgen zur pathologischen und vergleichenden Anatomie der Aderhaut. Albert von Graefes Arch Ophthalmol. 22:(Pt 2):1976;1-100.
18. Oeller JN. Atlas Seltener Ophthalmoskopischer Befunde. Zugleich Evgänzungstateln zu dem Atlas der Ophthalmoskopie. Weisbaden: JF Bergeman, 1900-1905
19. Junius P., Kuhnt H. Die scheibenförmige Entargung der Netzhautmitte (Degeneratio maculae luteae disciformis). 1926;132 Karger, Berlin.
20. Holloway T.B., Verhoeff F.H. Disc-like degeneration of the macula with microscopic report concerning a tumor-like mass in the macular region. Trans Am Ophthalmol Soc. 26:1928;206-228.
21. Verhoeff F.H., Grossman H.P. Pathogenesis of disciform degeneration of the macula. Arch Ophthalmol. 18:1937;561-585.
22. Ashton N., Sorsby A. Fundus dystrophy with unusual features A histological study. Br J Ophthalmol. 35:1951;751-764.
23. Sorsby A., Mason M.E.J. A fundus dystrophy with unusual features (late onset and dominant inheritance of a central retinal lesion showing oedema, haemorrhage, and exudates developing into generalized choroidal atrophy with massive pigment proliferation). Br J Ophthalmol. 33:1949;67-97.
24. Gass J.D.M. Pathogenesis of disciform detachment of the neuroepithelium. I. General concepts and classification. Am J Ophthalmol. 63:1967;573-585.
25. Gass J.D.M. Pathogenesis of disciform detachment of the neuroepithelium. III. Senile disciform degeneration. Am J Ophthalmol. 63:1967;617-644.
26. Gass J.D.M. Pathogenesis of disciform detachment of the neuroepithelium. IV. Fluorescein angiographic studies of senile disciform macular degeneration. Am J Ophthalmol. 63:1967;645-659.
27. Sarks S.H. New vessel formation beneath the retinal pigment epithelium in senile eyes. Br J Ophthalmol. 57:1973;951-965.
28. Green W.R., Key S.N. III. Senile macular degeneration A histopathologic study. Trans Am Ophthalmol Soc. 75:1977;180-254.
29. Lopez P.F., Grossniklaus H.E., Lambert H.M., et al. Pathologic features of surgically-excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 112:1991;647-656.
30. Saxe S.J., Grossniklaus H.E., Lopez P.F., et al. Ultrastructural features of surgically-excised subretinal neovascular membranes in the ocular histoplasmosis syndrome. Arch Ophthalmol. 111:1993;88-95.
31. Thomas J.W., Grossniklaus H.E., Lambert H.M., et al. Ultrastructural features of surgically-excised idiopathic subfoveal neovascular membranes. Retina. 13:1993;93-98.
32. Sarks S.H. Ageing and degeneration in the macular region A clinicopathologic study. Br J Ophthalmol. 60:1976;324-341.
33. Sarks S. Drusen and their relationship to senile macular degeneration. Aust J Ophthalmol. 8:1980;117-130.
34. Lopez P.F., Sippy B.D., Lambert H.M., et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 37:1996;855-868.
35. Kvanta A., Algvere P.V., Berglin L., Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 37:1996;1929-1934.
36. Bressler S.B., Silva J.R., Bressler N.M., et al. Clinicopathologic correlation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol. 110:1992;827-832.
37. Green W.R., Gass J.D.M. Senile disciform degeneration of the macula Retinal arterialization of the fibrous plaque demonstrated clinically and histopathologically. Arch Ophthalmol. 86:1971;487-494.
38. Olsen T.W., Capone A. Jr, Sternberg P. Jr, et al. Subfoveal choroidal neovascularization in punctate inner choroidopathy surgical management and pathologic findings. Ophthalmol. 103:1996;2061-2069.
39. Elner S.G., Streiten R.M., Elner V.M., et al. Monocyte dendritic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest. 64:1991;819-825.
40. Elner V.M., Streiten R.M., Elner S.G., et al. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol. 136:1996;745-750.
41. Dastgheib K., Green W.R. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol. 112:1994;813-818.
42. Oh H., Takagi H., Takagi C., et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 40:1999;1891-1898.
43. Otani A., Takagi H., Oh H., et al. Expression of angiopoietins and Tie2 in human choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 40:1999;1912-1920.
44. Hinton D.R., Zhao M.W., Jin M.L., et al. Signal transduction pathways controlling fibronectin phagocytosis by retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci. 40:1999;S181.
45. Grant M.B., May W.S., Caballero S., et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 6:2002;607-612.
46. Hattori K., Heissing B., Wu Y., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone marrow microenvironment. Nat Med. 8:2002;841-849.
47. Espinosa DG, Caicedo A, Hernandez EP, et al. Adult bone marrow derived progenitor cells contribute to choroidal neovascularization and modulate the severity. ARVO Abstracts 2003;3976
48. Steen B., Sejersen S., Berglin L., et al. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 39:1998;2194-2200.
49. Amin R., Puklin J.E., Frank R.N. Growth factor localization in choroidal neovascularization. Invest Ophthalmol Vis Sci. 35:1994;3178-3188.
50. Reddy V.M., Zamora R.L., Kaplan H.J. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 120:1995;291-301.
51. Ogata N., Yamamoto C., Miyashiro M., et al. Expression of transforming growth factor-beta mRNA in experimental choroidal neovascularization. Curr Eye Res. 16:1997;9-18.
52. Hangai M., Murata T., Miyawaki N., et al. Angiopoietin-1 upregulation by vascular endothelial growth factors in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 42:2001;1617-1625.
53. Schwartz SD, Tran D, Hsu YSJ, et al. Gene transfer of pigment epithelium-derived factor (PEDF) blocks laser-induced choroidal neovascularization (CNV) in male cynomolgus monkies. ARVO Abstracts 2002;3915
54. Yamashita J., Itoh H., Hirashima M., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 408:2000;92-96.
55. Luttun A., Dewerchine M., Collen D., et al. The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke Insights from genetic studies. Curr Atheroscler Res. 2:2000;407-416.
56. Penfold P., Killingsworth M., Sarks S. An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. Aust J Ophthalmol. 12:1984;23-31.
57. Penfold P.C., Killingsworth M.C., Sarks S.H. Senile macular degeneration The involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol. 223:1985;69-76.
58. Gass J.D.M. Choroidal neovascular membranes - their visualization and treatment. Trans Am Acad Ophthalmol Otolaryng. 77:1973;310-320.
59. Gass J.D.M. Drusen and disciform macular detachment and degeneration. Trans Am Ophthalmol Soc. 70:1972;409-436.
60. Watzke R.C., Syndeer W.B. Light coagulation for hemorrhagic disciform degeneration of the macula. Trans Am Acad Ophthalmol Otolaryngol. 72:1968;389-395.
61. Jepson C.N., Wetzig P.C. Photocoagulation of disciform macular degeneration. Am J Ophthalmol. 67:1969;920-930.
62. L'Esperance F.A. Jr. Argon and ruby laser photocoagulation of disciform macular disease. Trans Am Acad Otolaryngol. 75:1971;609-625.
63. Schatz H., Patz A. Exudative senile maculopathy. II. Complications of argon laser treatment. Arch Ophthalmol. 90:1973;197-202.
64. Bird A.C. Recent advances in the treatment of senile macular degeneration by photocoagulation. Br J Ophthalmol. 58:1974;367-376.
65. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration Results of a randomized clinical trial. Arch Ophthalmol. 100:1982;912-918.
66. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol. 108:1990;825-831.
67. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration Updated findings from two clinical trials. Arch Ophthalmol. 111:1993;1200-1209.
68. Macular Photocoagulation Study Group. Argon laser photocoagulation for ocular histoplasmosis Results of a randomized clinical trial. Arch Ophthalmol. 101:1983;1347-1357.
69. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions after ocular histoplasmosis. Arch Ophthalmol. 107:1989;344-352.
70. Macular Photocoagulation Study Group. Argon laser photocoagulation for idiopathic neovascularization Results of a randomized clinical trial. Arch Ophthalmol. 101:1983;1358-1361.
71. Treatment of Age-Related Macular Degeneration using Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin One-year results of 2 randomized clinical trials. TAP Report 1. Arch Ophthalmol. 117:1999;1329-1345.
72. Treatment of Age-Related Macular Degeneration using Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin - two year results of 2 randomized clinical trials. Tap Report 2. Arch Ophthalmol. 119:2001;198-207.
73. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin 1-Year results of a randomized clinical trial. VIP report no. 1. Ophthalmology. 108:2001;841-852.
74. De Juan E. Jr, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol. 105:1988;25-29.
75. Thomas M.A., Kaplan H.J. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 111:1991;1-7.
76. Lambert H.M., Capone A. Jr, Aaberg T.M., et al. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 113:1992;257-262.
77. Hsu J.K., Thomas M.A., Ibanez H., Green W.R. Clinicopathologic studies of an eye after submacular membranectomy for choroidal neovascularization. Retina. 15:1995;43-52.
78. Rosa R.H., Thomas M.A., Green W.R. Clinicopathologic correlation of submacular membranectomy with retention of good vision in a patient with age-related macular degeneration. Arch Ophthalmol. 114:1996;480-487.
79. Submacular Surgery Trials (SST) Study Group. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. I. Ophthalmic outcomes. Submacular Surgery Trials report number 1. Am J Ophthalmol. 130:2000;387-407.
80. De Juan E. Jr, Lowenstein A., Bressler N.M., et al. Translocation of the retina for the management of subfoveal choroidal neovascularization II A preliminary report in humans. Am J Ophthalmol. 25:1998;635-646.
81. Toth C.A., Friedman S.F. Macular translocation with 360-degree peripheral retinectomy Impact of technique and surgical experience on visual outcomes. Retina. 21:2001;293-303.
82. Grossniklaus H.E., Brooks H.L., Sippy B.D., Liu P. Retinal translocation and photodynamic therapy for age-related macular degeneration with classic choroidal neovascularization A clinicopathologic case report. Retina. 22:2002;818-824.
83. Marcus DM, Maguire MG, Maguire AM, Fine SL. The age-related macular degeneration radiotherapy trial: Baseline characteristics. ARVO Abstracts 2002;1207
84. Ciulla T.A., Griswell M.H., Danes R.P., Hill T.E. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol. 119:2001;399-404.
85. Ranson N.T., Danis R.D., Ciulla T.A., Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularization after laser treatment in macular degeneration. Br J Ophthalmol. 86:2002;527-529.
86. Penfold P.L., Wen L., Madigan M.C., et al. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line Implications for macular degeneration. Clin Exp Immunol. 121:2000;458-465.
87. Penn J.S., Rajaratnan V.S., Collier R.J., Clark A.F. The effect of an angiogenic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 42:2001;283-290.
88. D'Amico D.J., Goldberg M.F., Hudson H., et al. Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD) Interim (month 6) analysis of clinical safety and efficacy. Retina. 23:2003;14-23.
89. Krzystolik M.G., Afshari M.A., Adamis A.P., et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol. 120:2002;338-346.
90. Singerman LJ, for the EyeTech Study Group. Anti-VEGF therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: Phase 1B results. ARVO Abstracts 2002;2908
91. The EyeTech Study Group. Preclinical and phase 1a clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for treatment of exudative age-related macular degeneration. Retina. 22:2002;143-152.
92. Gehlbach P., Demetriades A.M., Yamamoto S., et al. Periocular injection of an adenoviral vector encoding pigment-epithelium derived factor inhibits choroidal neovascularization. Gene Ther. 10:2003;637-646.
93. Rasmussen H., Chu K.W., Campochiaro P., et al. Clinical protocol. An open-label, phase 1, single administration dose-escalation study of ADGVPEDF. 11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Hum Gene Ther. 12:2001;2029-2032.
94. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report No. 8. Arch Ophthalmol 2001;119:1417-1436